nodes	percent_of_prediction	percent_of_DWPC	metapath
Fusidic Acid—ABCB11—Doxorubicin—urinary bladder cancer	0.18	0.222	CbGbCtD
Fusidic Acid—ABCC2—Carboplatin—urinary bladder cancer	0.165	0.204	CbGbCtD
Fusidic Acid—ABCC2—Cisplatin—urinary bladder cancer	0.141	0.174	CbGbCtD
Fusidic Acid—ABCC2—Etoposide—urinary bladder cancer	0.139	0.171	CbGbCtD
Fusidic Acid—ABCC2—Doxorubicin—urinary bladder cancer	0.0946	0.117	CbGbCtD
Fusidic Acid—ABCC2—Methotrexate—urinary bladder cancer	0.0916	0.113	CbGbCtD
Fusidic Acid—Rash—Mitomycin—urinary bladder cancer	0.000764	0.00404	CcSEcCtD
Fusidic Acid—Dermatitis—Mitomycin—urinary bladder cancer	0.000763	0.00404	CcSEcCtD
Fusidic Acid—Bone disorder—Epirubicin—urinary bladder cancer	0.000761	0.00403	CcSEcCtD
Fusidic Acid—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.00076	0.00402	CcSEcCtD
Fusidic Acid—Headache—Mitomycin—urinary bladder cancer	0.000759	0.00401	CcSEcCtD
Fusidic Acid—Inflammation—Methotrexate—urinary bladder cancer	0.000757	0.00401	CcSEcCtD
Fusidic Acid—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00075	0.00397	CcSEcCtD
Fusidic Acid—Erythema—Thiotepa—urinary bladder cancer	0.000746	0.00395	CcSEcCtD
Fusidic Acid—Lacrimation increased—Epirubicin—urinary bladder cancer	0.000746	0.00395	CcSEcCtD
Fusidic Acid—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.000737	0.0039	CcSEcCtD
Fusidic Acid—Pancytopenia—Etoposide—urinary bladder cancer	0.000731	0.00387	CcSEcCtD
Fusidic Acid—Conjunctivitis—Cisplatin—urinary bladder cancer	0.000728	0.00385	CcSEcCtD
Fusidic Acid—Neutropenia—Etoposide—urinary bladder cancer	0.000719	0.00381	CcSEcCtD
Fusidic Acid—Nausea—Mitomycin—urinary bladder cancer	0.000719	0.00381	CcSEcCtD
Fusidic Acid—Inflammation—Epirubicin—urinary bladder cancer	0.000709	0.00375	CcSEcCtD
Fusidic Acid—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.000708	0.00375	CcSEcCtD
Fusidic Acid—Bone disorder—Doxorubicin—urinary bladder cancer	0.000704	0.00373	CcSEcCtD
Fusidic Acid—Vision blurred—Thiotepa—urinary bladder cancer	0.000703	0.00372	CcSEcCtD
Fusidic Acid—Lacrimation increased—Doxorubicin—urinary bladder cancer	0.00069	0.00365	CcSEcCtD
Fusidic Acid—Anaemia—Thiotepa—urinary bladder cancer	0.00069	0.00365	CcSEcCtD
Fusidic Acid—Jaundice—Etoposide—urinary bladder cancer	0.000669	0.00354	CcSEcCtD
Fusidic Acid—Leukopenia—Thiotepa—urinary bladder cancer	0.000668	0.00353	CcSEcCtD
Fusidic Acid—Inflammation—Doxorubicin—urinary bladder cancer	0.000656	0.00347	CcSEcCtD
Fusidic Acid—Immune system disorder—Gemcitabine—urinary bladder cancer	0.000651	0.00345	CcSEcCtD
Fusidic Acid—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.000649	0.00343	CcSEcCtD
Fusidic Acid—Arrhythmia—Gemcitabine—urinary bladder cancer	0.000644	0.00341	CcSEcCtD
Fusidic Acid—Agranulocytosis—Etoposide—urinary bladder cancer	0.00064	0.00339	CcSEcCtD
Fusidic Acid—Arrhythmia—Fluorouracil—urinary bladder cancer	0.000633	0.00335	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000631	0.00334	CcSEcCtD
Fusidic Acid—Eye disorder—Cisplatin—urinary bladder cancer	0.000628	0.00332	CcSEcCtD
Fusidic Acid—Erythema—Gemcitabine—urinary bladder cancer	0.000628	0.00332	CcSEcCtD
Fusidic Acid—Erythema—Fluorouracil—urinary bladder cancer	0.000617	0.00327	CcSEcCtD
Fusidic Acid—Thrombophlebitis—Methotrexate—urinary bladder cancer	0.000616	0.00326	CcSEcCtD
Fusidic Acid—Immune system disorder—Cisplatin—urinary bladder cancer	0.000607	0.00321	CcSEcCtD
Fusidic Acid—Arrhythmia—Cisplatin—urinary bladder cancer	0.0006	0.00318	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000596	0.00315	CcSEcCtD
Fusidic Acid—Skin disorder—Thiotepa—urinary bladder cancer	0.000592	0.00313	CcSEcCtD
Fusidic Acid—Erythema—Cisplatin—urinary bladder cancer	0.000585	0.0031	CcSEcCtD
Fusidic Acid—Vision blurred—Fluorouracil—urinary bladder cancer	0.000582	0.00308	CcSEcCtD
Fusidic Acid—Anorexia—Thiotepa—urinary bladder cancer	0.000581	0.00307	CcSEcCtD
Fusidic Acid—Anaemia—Gemcitabine—urinary bladder cancer	0.00058	0.00307	CcSEcCtD
Fusidic Acid—Renal failure acute—Methotrexate—urinary bladder cancer	0.000578	0.00306	CcSEcCtD
Fusidic Acid—Flatulence—Cisplatin—urinary bladder cancer	0.000577	0.00305	CcSEcCtD
Fusidic Acid—Thrombophlebitis—Epirubicin—urinary bladder cancer	0.000576	0.00305	CcSEcCtD
Fusidic Acid—Eye disorder—Etoposide—urinary bladder cancer	0.000575	0.00304	CcSEcCtD
Fusidic Acid—Anaemia—Fluorouracil—urinary bladder cancer	0.00057	0.00302	CcSEcCtD
Fusidic Acid—Leukopenia—Gemcitabine—urinary bladder cancer	0.000562	0.00297	CcSEcCtD
Fusidic Acid—Immune system disorder—Etoposide—urinary bladder cancer	0.000556	0.00294	CcSEcCtD
Fusidic Acid—Eye pain—Epirubicin—urinary bladder cancer	0.000553	0.00292	CcSEcCtD
Fusidic Acid—Leukopenia—Fluorouracil—urinary bladder cancer	0.000552	0.00292	CcSEcCtD
Fusidic Acid—Vision blurred—Cisplatin—urinary bladder cancer	0.000551	0.00292	CcSEcCtD
Fusidic Acid—Lethargy—Methotrexate—urinary bladder cancer	0.000544	0.00288	CcSEcCtD
Fusidic Acid—Anaemia—Cisplatin—urinary bladder cancer	0.000541	0.00286	CcSEcCtD
Fusidic Acid—Renal failure acute—Epirubicin—urinary bladder cancer	0.00054	0.00286	CcSEcCtD
Fusidic Acid—Dyspepsia—Thiotepa—urinary bladder cancer	0.000536	0.00284	CcSEcCtD
Fusidic Acid—Thrombophlebitis—Doxorubicin—urinary bladder cancer	0.000533	0.00282	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000531	0.00281	CcSEcCtD
Fusidic Acid—Decreased appetite—Thiotepa—urinary bladder cancer	0.000529	0.0028	CcSEcCtD
Fusidic Acid—Discomfort—Gemcitabine—urinary bladder cancer	0.000528	0.00279	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000526	0.00278	CcSEcCtD
Fusidic Acid—Leukopenia—Cisplatin—urinary bladder cancer	0.000524	0.00277	CcSEcCtD
Fusidic Acid—Pain—Thiotepa—urinary bladder cancer	0.000521	0.00276	CcSEcCtD
Fusidic Acid—Discomfort—Fluorouracil—urinary bladder cancer	0.000519	0.00275	CcSEcCtD
Fusidic Acid—Eye pain—Doxorubicin—urinary bladder cancer	0.000511	0.00271	CcSEcCtD
Fusidic Acid—Lethargy—Epirubicin—urinary bladder cancer	0.000509	0.00269	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000502	0.00265	CcSEcCtD
Fusidic Acid—Renal failure acute—Doxorubicin—urinary bladder cancer	0.0005	0.00265	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000498	0.00263	CcSEcCtD
Fusidic Acid—Skin disorder—Gemcitabine—urinary bladder cancer	0.000498	0.00263	CcSEcCtD
Fusidic Acid—Anaemia—Etoposide—urinary bladder cancer	0.000495	0.00262	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000495	0.00262	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000493	0.00261	CcSEcCtD
Fusidic Acid—Discomfort—Cisplatin—urinary bladder cancer	0.000492	0.0026	CcSEcCtD
Fusidic Acid—Anorexia—Gemcitabine—urinary bladder cancer	0.000488	0.00258	CcSEcCtD
Fusidic Acid—Urticaria—Thiotepa—urinary bladder cancer	0.000484	0.00256	CcSEcCtD
Fusidic Acid—Abdominal pain—Thiotepa—urinary bladder cancer	0.000481	0.00255	CcSEcCtD
Fusidic Acid—Anorexia—Fluorouracil—urinary bladder cancer	0.00048	0.00254	CcSEcCtD
Fusidic Acid—Leukopenia—Etoposide—urinary bladder cancer	0.00048	0.00254	CcSEcCtD
Fusidic Acid—Lethargy—Doxorubicin—urinary bladder cancer	0.000471	0.00249	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000468	0.00247	CcSEcCtD
Fusidic Acid—Skin disorder—Cisplatin—urinary bladder cancer	0.000464	0.00245	CcSEcCtD
Fusidic Acid—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.000456	0.00241	CcSEcCtD
Fusidic Acid—Anorexia—Cisplatin—urinary bladder cancer	0.000455	0.00241	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000453	0.0024	CcSEcCtD
Fusidic Acid—Discomfort—Etoposide—urinary bladder cancer	0.000451	0.00239	CcSEcCtD
Fusidic Acid—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000449	0.00237	CcSEcCtD
Fusidic Acid—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000445	0.00236	CcSEcCtD
Fusidic Acid—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000443	0.00235	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000442	0.00234	CcSEcCtD
Fusidic Acid—Muscular weakness—Epirubicin—urinary bladder cancer	0.00044	0.00233	CcSEcCtD
Fusidic Acid—Pain—Gemcitabine—urinary bladder cancer	0.000438	0.00232	CcSEcCtD
Fusidic Acid—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000438	0.00232	CcSEcCtD
Fusidic Acid—Pancytopenia—Methotrexate—urinary bladder cancer	0.000438	0.00232	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000435	0.0023	CcSEcCtD
Fusidic Acid—Neutropenia—Methotrexate—urinary bladder cancer	0.000431	0.00228	CcSEcCtD
Fusidic Acid—Pruritus—Thiotepa—urinary bladder cancer	0.000431	0.00228	CcSEcCtD
Fusidic Acid—Pain—Fluorouracil—urinary bladder cancer	0.000431	0.00228	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000428	0.00227	CcSEcCtD
Fusidic Acid—Skin disorder—Etoposide—urinary bladder cancer	0.000425	0.00225	CcSEcCtD
Fusidic Acid—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000422	0.00223	CcSEcCtD
Fusidic Acid—Anorexia—Etoposide—urinary bladder cancer	0.000417	0.00221	CcSEcCtD
Fusidic Acid—Diarrhoea—Thiotepa—urinary bladder cancer	0.000417	0.0022	CcSEcCtD
Fusidic Acid—Decreased appetite—Cisplatin—urinary bladder cancer	0.000415	0.0022	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000412	0.00218	CcSEcCtD
Fusidic Acid—Pancytopenia—Epirubicin—urinary bladder cancer	0.00041	0.00217	CcSEcCtD
Fusidic Acid—Pain—Cisplatin—urinary bladder cancer	0.000408	0.00216	CcSEcCtD
Fusidic Acid—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000407	0.00215	CcSEcCtD
Fusidic Acid—Neutropenia—Epirubicin—urinary bladder cancer	0.000403	0.00213	CcSEcCtD
Fusidic Acid—Dizziness—Thiotepa—urinary bladder cancer	0.000403	0.00213	CcSEcCtD
Fusidic Acid—Urticaria—Fluorouracil—urinary bladder cancer	0.0004	0.00212	CcSEcCtD
Fusidic Acid—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000399	0.00211	CcSEcCtD
Fusidic Acid—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000389	0.00206	CcSEcCtD
Fusidic Acid—Vomiting—Thiotepa—urinary bladder cancer	0.000387	0.00205	CcSEcCtD
Fusidic Acid—Rash—Thiotepa—urinary bladder cancer	0.000384	0.00203	CcSEcCtD
Fusidic Acid—Dermatitis—Thiotepa—urinary bladder cancer	0.000384	0.00203	CcSEcCtD
Fusidic Acid—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000383	0.00203	CcSEcCtD
Fusidic Acid—Headache—Thiotepa—urinary bladder cancer	0.000382	0.00202	CcSEcCtD
Fusidic Acid—Decreased appetite—Etoposide—urinary bladder cancer	0.00038	0.00201	CcSEcCtD
Fusidic Acid—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000379	0.002	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000378	0.002	CcSEcCtD
Fusidic Acid—Jaundice—Epirubicin—urinary bladder cancer	0.000375	0.00198	CcSEcCtD
Fusidic Acid—Pain—Etoposide—urinary bladder cancer	0.000374	0.00198	CcSEcCtD
Fusidic Acid—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000374	0.00198	CcSEcCtD
Fusidic Acid—Neutropenia—Doxorubicin—urinary bladder cancer	0.000373	0.00197	CcSEcCtD
Fusidic Acid—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000371	0.00196	CcSEcCtD
Fusidic Acid—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000364	0.00192	CcSEcCtD
Fusidic Acid—Pruritus—Gemcitabine—urinary bladder cancer	0.000362	0.00192	CcSEcCtD
Fusidic Acid—Nausea—Thiotepa—urinary bladder cancer	0.000362	0.00191	CcSEcCtD
Fusidic Acid—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000359	0.0019	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000358	0.00189	CcSEcCtD
Fusidic Acid—Pruritus—Fluorouracil—urinary bladder cancer	0.000356	0.00189	CcSEcCtD
Fusidic Acid—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000352	0.00186	CcSEcCtD
Fusidic Acid—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000351	0.00185	CcSEcCtD
Fusidic Acid—Urticaria—Etoposide—urinary bladder cancer	0.000348	0.00184	CcSEcCtD
Fusidic Acid—Jaundice—Doxorubicin—urinary bladder cancer	0.000347	0.00183	CcSEcCtD
Fusidic Acid—Abdominal pain—Etoposide—urinary bladder cancer	0.000346	0.00183	CcSEcCtD
Fusidic Acid—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000346	0.00183	CcSEcCtD
Fusidic Acid—Eye disorder—Methotrexate—urinary bladder cancer	0.000345	0.00182	CcSEcCtD
Fusidic Acid—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000345	0.00182	CcSEcCtD
Fusidic Acid—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000336	0.00178	CcSEcCtD
Fusidic Acid—Immune system disorder—Methotrexate—urinary bladder cancer	0.000333	0.00176	CcSEcCtD
Fusidic Acid—Dizziness—Fluorouracil—urinary bladder cancer	0.000333	0.00176	CcSEcCtD
Fusidic Acid—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000332	0.00176	CcSEcCtD
Fusidic Acid—Diarrhoea—Cisplatin—urinary bladder cancer	0.000327	0.00173	CcSEcCtD
Fusidic Acid—Vomiting—Gemcitabine—urinary bladder cancer	0.000326	0.00172	CcSEcCtD
Fusidic Acid—Rash—Gemcitabine—urinary bladder cancer	0.000323	0.00171	CcSEcCtD
Fusidic Acid—Dermatitis—Gemcitabine—urinary bladder cancer	0.000323	0.00171	CcSEcCtD
Fusidic Acid—Eye disorder—Epirubicin—urinary bladder cancer	0.000323	0.00171	CcSEcCtD
Fusidic Acid—Hypersensitivity—Etoposide—urinary bladder cancer	0.000322	0.00171	CcSEcCtD
Fusidic Acid—Erythema—Methotrexate—urinary bladder cancer	0.000321	0.0017	CcSEcCtD
Fusidic Acid—Headache—Gemcitabine—urinary bladder cancer	0.000321	0.0017	CcSEcCtD
Fusidic Acid—Vomiting—Fluorouracil—urinary bladder cancer	0.00032	0.00169	CcSEcCtD
Fusidic Acid—Rash—Fluorouracil—urinary bladder cancer	0.000318	0.00168	CcSEcCtD
Fusidic Acid—Dermatitis—Fluorouracil—urinary bladder cancer	0.000317	0.00168	CcSEcCtD
Fusidic Acid—Headache—Fluorouracil—urinary bladder cancer	0.000316	0.00167	CcSEcCtD
Fusidic Acid—Immune system disorder—Epirubicin—urinary bladder cancer	0.000312	0.00165	CcSEcCtD
Fusidic Acid—Pruritus—Etoposide—urinary bladder cancer	0.00031	0.00164	CcSEcCtD
Fusidic Acid—Arrhythmia—Epirubicin—urinary bladder cancer	0.000308	0.00163	CcSEcCtD
Fusidic Acid—Nausea—Gemcitabine—urinary bladder cancer	0.000304	0.00161	CcSEcCtD
Fusidic Acid—Vomiting—Cisplatin—urinary bladder cancer	0.000304	0.00161	CcSEcCtD
Fusidic Acid—Vision blurred—Methotrexate—urinary bladder cancer	0.000303	0.0016	CcSEcCtD
Fusidic Acid—Rash—Cisplatin—urinary bladder cancer	0.000301	0.00159	CcSEcCtD
Fusidic Acid—Dermatitis—Cisplatin—urinary bladder cancer	0.000301	0.00159	CcSEcCtD
Fusidic Acid—Erythema—Epirubicin—urinary bladder cancer	0.0003	0.00159	CcSEcCtD
Fusidic Acid—Diarrhoea—Etoposide—urinary bladder cancer	0.000299	0.00158	CcSEcCtD
Fusidic Acid—Nausea—Fluorouracil—urinary bladder cancer	0.000299	0.00158	CcSEcCtD
Fusidic Acid—Eye disorder—Doxorubicin—urinary bladder cancer	0.000298	0.00158	CcSEcCtD
Fusidic Acid—Anaemia—Methotrexate—urinary bladder cancer	0.000297	0.00157	CcSEcCtD
Fusidic Acid—Flatulence—Epirubicin—urinary bladder cancer	0.000296	0.00157	CcSEcCtD
Fusidic Acid—Dizziness—Etoposide—urinary bladder cancer	0.000289	0.00153	CcSEcCtD
Fusidic Acid—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000288	0.00153	CcSEcCtD
Fusidic Acid—Leukopenia—Methotrexate—urinary bladder cancer	0.000287	0.00152	CcSEcCtD
Fusidic Acid—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000285	0.00151	CcSEcCtD
Fusidic Acid—Nausea—Cisplatin—urinary bladder cancer	0.000284	0.0015	CcSEcCtD
Fusidic Acid—Vision blurred—Epirubicin—urinary bladder cancer	0.000283	0.0015	CcSEcCtD
Fusidic Acid—Vomiting—Etoposide—urinary bladder cancer	0.000278	0.00147	CcSEcCtD
Fusidic Acid—Erythema—Doxorubicin—urinary bladder cancer	0.000278	0.00147	CcSEcCtD
Fusidic Acid—Anaemia—Epirubicin—urinary bladder cancer	0.000278	0.00147	CcSEcCtD
Fusidic Acid—Rash—Etoposide—urinary bladder cancer	0.000276	0.00146	CcSEcCtD
Fusidic Acid—Dermatitis—Etoposide—urinary bladder cancer	0.000276	0.00146	CcSEcCtD
Fusidic Acid—Headache—Etoposide—urinary bladder cancer	0.000274	0.00145	CcSEcCtD
Fusidic Acid—Flatulence—Doxorubicin—urinary bladder cancer	0.000274	0.00145	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000271	0.00144	CcSEcCtD
Fusidic Acid—Discomfort—Methotrexate—urinary bladder cancer	0.00027	0.00143	CcSEcCtD
Fusidic Acid—Leukopenia—Epirubicin—urinary bladder cancer	0.000269	0.00142	CcSEcCtD
Fusidic Acid—Vision blurred—Doxorubicin—urinary bladder cancer	0.000262	0.00139	CcSEcCtD
Fusidic Acid—Nausea—Etoposide—urinary bladder cancer	0.00026	0.00137	CcSEcCtD
Fusidic Acid—Anaemia—Doxorubicin—urinary bladder cancer	0.000257	0.00136	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000257	0.00136	CcSEcCtD
Fusidic Acid—Skin disorder—Methotrexate—urinary bladder cancer	0.000255	0.00135	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000254	0.00134	CcSEcCtD
Fusidic Acid—Discomfort—Epirubicin—urinary bladder cancer	0.000253	0.00134	CcSEcCtD
Fusidic Acid—Anorexia—Methotrexate—urinary bladder cancer	0.00025	0.00132	CcSEcCtD
Fusidic Acid—Leukopenia—Doxorubicin—urinary bladder cancer	0.000249	0.00132	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00024	0.00127	CcSEcCtD
Fusidic Acid—Skin disorder—Epirubicin—urinary bladder cancer	0.000238	0.00126	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000235	0.00124	CcSEcCtD
Fusidic Acid—Discomfort—Doxorubicin—urinary bladder cancer	0.000234	0.00124	CcSEcCtD
Fusidic Acid—Anorexia—Epirubicin—urinary bladder cancer	0.000234	0.00124	CcSEcCtD
Fusidic Acid—Dyspepsia—Methotrexate—urinary bladder cancer	0.000231	0.00122	CcSEcCtD
Fusidic Acid—Decreased appetite—Methotrexate—urinary bladder cancer	0.000228	0.00121	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000226	0.0012	CcSEcCtD
Fusidic Acid—Pain—Methotrexate—urinary bladder cancer	0.000224	0.00119	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000222	0.00118	CcSEcCtD
Fusidic Acid—Skin disorder—Doxorubicin—urinary bladder cancer	0.00022	0.00117	CcSEcCtD
Fusidic Acid—Anorexia—Doxorubicin—urinary bladder cancer	0.000216	0.00114	CcSEcCtD
Fusidic Acid—Dyspepsia—Epirubicin—urinary bladder cancer	0.000216	0.00114	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000214	0.00113	CcSEcCtD
Fusidic Acid—Decreased appetite—Epirubicin—urinary bladder cancer	0.000213	0.00113	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000212	0.00112	CcSEcCtD
Fusidic Acid—Pain—Epirubicin—urinary bladder cancer	0.00021	0.00111	CcSEcCtD
Fusidic Acid—Urticaria—Methotrexate—urinary bladder cancer	0.000208	0.0011	CcSEcCtD
Fusidic Acid—Abdominal pain—Methotrexate—urinary bladder cancer	0.000207	0.0011	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000201	0.00106	CcSEcCtD
Fusidic Acid—Dyspepsia—Doxorubicin—urinary bladder cancer	0.0002	0.00106	CcSEcCtD
Fusidic Acid—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000197	0.00104	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000196	0.00104	CcSEcCtD
Fusidic Acid—Urticaria—Epirubicin—urinary bladder cancer	0.000195	0.00103	CcSEcCtD
Fusidic Acid—Pain—Doxorubicin—urinary bladder cancer	0.000194	0.00103	CcSEcCtD
Fusidic Acid—Abdominal pain—Epirubicin—urinary bladder cancer	0.000194	0.00103	CcSEcCtD
Fusidic Acid—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000193	0.00102	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000186	0.000982	CcSEcCtD
Fusidic Acid—Pruritus—Methotrexate—urinary bladder cancer	0.000185	0.000981	CcSEcCtD
Fusidic Acid—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000181	0.000956	CcSEcCtD
Fusidic Acid—Urticaria—Doxorubicin—urinary bladder cancer	0.00018	0.000954	CcSEcCtD
Fusidic Acid—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000179	0.000949	CcSEcCtD
Fusidic Acid—Diarrhoea—Methotrexate—urinary bladder cancer	0.000179	0.000949	CcSEcCtD
Fusidic Acid—Pruritus—Epirubicin—urinary bladder cancer	0.000174	0.000918	CcSEcCtD
Fusidic Acid—Dizziness—Methotrexate—urinary bladder cancer	0.000173	0.000917	CcSEcCtD
Fusidic Acid—Diarrhoea—Epirubicin—urinary bladder cancer	0.000168	0.000888	CcSEcCtD
Fusidic Acid—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000167	0.000884	CcSEcCtD
Fusidic Acid—Vomiting—Methotrexate—urinary bladder cancer	0.000167	0.000881	CcSEcCtD
Fusidic Acid—Rash—Methotrexate—urinary bladder cancer	0.000165	0.000874	CcSEcCtD
Fusidic Acid—Dermatitis—Methotrexate—urinary bladder cancer	0.000165	0.000873	CcSEcCtD
Fusidic Acid—Headache—Methotrexate—urinary bladder cancer	0.000164	0.000868	CcSEcCtD
Fusidic Acid—Dizziness—Epirubicin—urinary bladder cancer	0.000162	0.000858	CcSEcCtD
Fusidic Acid—Pruritus—Doxorubicin—urinary bladder cancer	0.000161	0.000849	CcSEcCtD
Fusidic Acid—Vomiting—Epirubicin—urinary bladder cancer	0.000156	0.000825	CcSEcCtD
Fusidic Acid—Nausea—Methotrexate—urinary bladder cancer	0.000156	0.000823	CcSEcCtD
Fusidic Acid—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000155	0.000821	CcSEcCtD
Fusidic Acid—Rash—Epirubicin—urinary bladder cancer	0.000155	0.000818	CcSEcCtD
Fusidic Acid—Dermatitis—Epirubicin—urinary bladder cancer	0.000154	0.000817	CcSEcCtD
Fusidic Acid—Headache—Epirubicin—urinary bladder cancer	0.000154	0.000813	CcSEcCtD
Fusidic Acid—Dizziness—Doxorubicin—urinary bladder cancer	0.00015	0.000794	CcSEcCtD
Fusidic Acid—Nausea—Epirubicin—urinary bladder cancer	0.000146	0.000771	CcSEcCtD
Fusidic Acid—Vomiting—Doxorubicin—urinary bladder cancer	0.000144	0.000763	CcSEcCtD
Fusidic Acid—Rash—Doxorubicin—urinary bladder cancer	0.000143	0.000757	CcSEcCtD
Fusidic Acid—Dermatitis—Doxorubicin—urinary bladder cancer	0.000143	0.000756	CcSEcCtD
Fusidic Acid—Headache—Doxorubicin—urinary bladder cancer	0.000142	0.000752	CcSEcCtD
Fusidic Acid—Nausea—Doxorubicin—urinary bladder cancer	0.000135	0.000713	CcSEcCtD
